Source: George S. Mack of The Life Sciences Report (3/6/14) www.thelifesciencesreport.com/pub/na/shi... Prospecting for hidden biotech gems makes sense, says H.C. Wainwright & Co. Managing Director George Zavoico, who recently joined the firm's ... Seeking Alpha, 1 month ago
1 images for "biotechnology regulatory authority of india b"
Isolation and characterization of Dehydration-Responsive Element-Binding Factor 2 (DREB2) from Indian wheat (Triticum aestivum L.) cultivars [Australian Journal of Crop Science]
[February 28, 2014] (Australian Journal of Crop Science Via Acquire Media NewsEdge) Abstract Plants have developed a sophisticated stress response system to cope with and adapt to different types of abiotic stress imposed by the ...TMC Net, 1 month ago
The cash position of the company amounts to EUR 19.4 M Regulatory News: Adocia (Euronext Paris : FR0011184241 - ADOC), a biotechnology company specialized in the development of 'best-in-class' medicines from already approved ...4 Traders, 1 month ago ADOCIA: annual revenue of EUR 5.6 M in 2013 Reuters, 1 month ago
Network Analysis of Inflammatory Genes and Their Transcriptional Regulators in Coronary Artery Disease
Network analysis is a novel method to understand the complex pathogenesis of inflammation-driven atherosclerosis. Using this approach, we attempted to identify key inflammatory genes and their core transcriptional regulators in coronary artery ...PLoS Medicine, 1 day ago
Omega-3 Polyunsaturated Fatty Acids (PUFAs) - 2014 Global Market Overview with Company Profiles on 42 Key Global Players in the Industry
India PRwire 2014-03-07 Research and Markets (http://www.researchandmarkets.com/research/5s52t7/omega3) has announced the addition of the "Omega-3 Polyunsaturated Fatty Acids (PUFAs) - A Global Market Overview" report to their offering. March 7, ...BizWire Express, 1 month ago Global Veterinary Vaccines Industry Yahoo! Finance, 1 day ago (mHealth) Mobile Healthcare Market to Hit $9 Billion in 2014 Sys-Con India, 1 month ago Orphan Drugs for CNS Diseases: R&D and Market 2014-2024 PR Newswire, 1 month ago
John Lothian Newsletter: Nasdaq OMX gets go ahead for clearing house under new rules; Australia regulators to probe forex price-rigging; EU legal opinion opens door to Tobin tax on forex
First Read Bits and Pieces By John J. Lothian Yesterday was the one-year anniversary of my new knees. On March 18, 2013, I underwent a double knee replacement, which has substantially made my life better. I am however, not without pain, as I ...John Lothian Newsletter, 4 weeks ago John Lothian Newsletter: CBOE toughens trader rules, following SEC fine last year; Australian exchange appeals to queue-weary Chinese companies; ISDA stymied over derivatives contracts rewrite John Lothian Newsletter, 1 month ago
Baxter Meets Primary Efficacy Endpoint in Phase 3 Trial of BAX 111, Investigational Stand-Alone Recombinant Treatment for von Willebrand Disease
B DEERFIELD, Ill. --(Business Wire)-- Baxter International Inc. (NYSE:BAX) today announced topline results from a Phase 3 clinical trial evaluating the safety, efficacy and pharmacokinetics (PK) of BAX 111. BAX 111 is a recombinant von Willebrand ...TMC Net, 15 hours ago
This report provides you with the knowledge to understand the current state of the advanced wound care market, the historical market background and the key companies who currently operate here. It is essential reading for anyone who needs to plan, ...Sys-Con Canada, 2 days ago
More from: , Sys-Con Australia...and 1 other sources
) - BLVD Holdings Inc. (the "Company") (OTCQB:BLVO) - Today John G. Simmonds, Chairman and CEO of BLVD Holdings Inc. , is pleased to announce a name change, new board and senior management appointments. www.acsimmondsandsons.com BLVD Holdings, ...4 Traders, 1 week ago BLVD Holdings Inc.: Name Change, New Board of Directors and Senior Management Appointments TMC Net, 1 week ago
RADIUS HEALTH, INC. - 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
You should read the following discussions in conjunction with our consolidated financial statements and related notes included in this report. This discussion includes forward-looking statements that involve risk and uncertainties. As a result of ...HispanicBusiness.com, 1 week ago CANCER GENETICS, INC - 10-K - Management's Discussion and Analysis of Financial Condition and Results of Operations TMC Net, 2 weeks ago NOVAVAX INC - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS HispanicBusiness.com, 1 month ago
on your WebpageAdd Widget >Get your members hooked!